Deflazacort is a synthetic glucocorticoid and an oxazoline derivative of prednisolone with anti-inflammatory and immunosuppressive activity. It is an ester prodrug and metabolized to form the active metabolite 21-desacetyldeflazacort.
Disposition of a new steroidal anti-inflammatory agent, deflazacort, in rat, dog and man. 
Deflazacort. A review of its pharmacological properties and therapeutic efficacy. 
Deflazacort: a glucocorticoid with few metabolic adverse effects but important immunosuppressive activity. 
Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids. 
 A.Alessandro, et al, Eur. J. Drug Metab. Pharmacokinet., 1980, 5(4), pp 207-215.
 A.Markham, et al, Drugs, 1995, 50(2), pp 317-333.
 O.Gonzalez-Perez, et al, Adv. Ther., 2007, 24(5), pp 1052-1060.
 L.Parente, et al, BMC Pharmacol. Toxicol., 2017, 18:1.